Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
bodySCULPT is a premier plastic surgery practice and clinical research center based in Manhattan, New York, specializing in advanced body contouring and aesthetic procedures. Led by Dr. Spero Theodorou and Dr. Christopher Chia, the facility is recognized as a global leader in the development and application of radiofrequency-assisted lipolysis (RFAL) technology. The practice serves as a key clinical research and training site for InMode, contributing to the refinement of widely used technologies such as BodyTite, FaceTite, and Morpheus8. bodySCULPT provides a comprehensive range of services, from minimally invasive treatments to complex surgical interventions, focusing on fat reduction, skin tightening, and facial rejuvenation. The center is also known for its expertise in treating specialized conditions like lipedema and gynecomastia. Through its dual role as a healthcare provider and an innovation hub, bodySCULPT remains at the forefront of the aesthetic medicine industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on bodySCULPT.